140 related articles for article (PubMed ID: 28188897)
21. Rising Oseltamivir Use Among Hospitalized Children in a Postpandemic Era.
Williams JT; Cunningham MA; Wilson KM; Rao S
Hosp Pediatr; 2016 Mar; 6(3):172-8. PubMed ID: 26908818
[TBL] [Abstract][Full Text] [Related]
22. Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
Saito R; Sato I; Suzuki Y; Baranovich T; Matsuda R; Ishitani N; Dapat C; Dapat IC; Zaraket H; Oguma T; Suzuki H
Pediatr Infect Dis J; 2010 Oct; 29(10):898-904. PubMed ID: 20442686
[TBL] [Abstract][Full Text] [Related]
23. Oseltamivir and early deterioration leading to death: a proportional mortality study for 2009A/H1N1 influenza.
Hama R; Jones M; Okushima H; Kitao M; Noda N; Hayashi K; Sakaguchi K
Int J Risk Saf Med; 2011; 23(4):201-15. PubMed ID: 22156085
[TBL] [Abstract][Full Text] [Related]
24. Benefit of early treatment with oseltamivir in hospitalized patients with documented 2009 influenza A (H1N1): retrospective cohort study.
Hiba V; Chowers M; Levi-Vinograd I; Rubinovitch B; Leibovici L; Paul M
J Antimicrob Chemother; 2011 May; 66(5):1150-5. PubMed ID: 21393197
[TBL] [Abstract][Full Text] [Related]
25. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
26. Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.
Sugaya N; Sakai-Tagawa Y; Bamba M; Yasuhara R; Yamazaki M; Kawakami C; Yamaguchi Y; Ide Y; Ichikawa M; Mitamura K; Kawaoka Y
Antivir Ther; 2015; 20(1):49-55. PubMed ID: 24832015
[TBL] [Abstract][Full Text] [Related]
27. Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
Renaud C; Kuypers J; Englund JA
J Clin Virol; 2011 Oct; 52(2):70-8. PubMed ID: 21684202
[TBL] [Abstract][Full Text] [Related]
28. Global transmission of oseltamivir-resistant influenza.
Moscona A
N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250
[No Abstract] [Full Text] [Related]
29. [Molecular genetic studies of the susceptibility of epidemic influenza A(H1N1) virus strains isolated in the 2006-2009 seasons in Russia to oseltamivir (Tamiflu)].
Beliakova NV; Al'khovskiĭ SV; Shevchenko ES; Prilipov AG; Abramov DD; Kolobukhina LV; Merkulova LN; Trushakova SV; Burtseva EI
Vopr Virusol; 2010; 55(5):10-3. PubMed ID: 21260988
[TBL] [Abstract][Full Text] [Related]
30. UK swine flu cases near 3000, as GP leader says use of Tamiflu may need to be rethought.
O'Dowd A
BMJ; 2009 Jun; 338():b2565. PubMed ID: 19549666
[No Abstract] [Full Text] [Related]
31. Effectiveness of Oseltamivir in reducing 30-day readmissions and mortality among patients with severe seasonal influenza in Australian hospitalized patients.
Sharma Y; Horwood C; Hakendorf P; Thompson C
Int J Infect Dis; 2021 Mar; 104():232-238. PubMed ID: 33434667
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and outcome of patients with pandemic 2009 Influenza A(H1N1)v virus infection admitted to hospitals with different levels of health-care.
Gutiérrez-Cuadra M; González-Fernández JL; Rodríguez-Cundin P; Fariñas-Álvarez C; San Juan MV; Parra JA; Carrascosa M; Fariñas MC
Rev Esp Quimioter; 2012 Mar; 25(1):56-64. PubMed ID: 22488543
[TBL] [Abstract][Full Text] [Related]
33. Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes.
Katzen J; Kohn R; Houk JL; Ison MG
Clin Infect Dis; 2019 Jun; 69(1):52-58. PubMed ID: 30304487
[TBL] [Abstract][Full Text] [Related]
34. [Naturally occurring oseltamivir resistance in influenza A].
Madsen L; Nielsen A; Lundgren J
Ugeskr Laeger; 2010 Aug; 172(32):2165-7. PubMed ID: 20696118
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection.
Groeneveld GH; Marbus SD; Ismail N; de Vries JJC; Schneeberger P; Oosterheert JJ; van Dissel JT; de Boer MGJ
Int J Antimicrob Agents; 2020 Nov; 56(5):106155. PubMed ID: 32898685
[TBL] [Abstract][Full Text] [Related]
36. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
[TBL] [Abstract][Full Text] [Related]
37. [Influenza A, pregnancy and neuraminidase inhibitors].
Montané E; Lecumberri J; Pedro-Botet ML
Med Clin (Barc); 2011 May; 136(15):688-93. PubMed ID: 20416906
[TBL] [Abstract][Full Text] [Related]
38. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and clinical outcome of H1N1 in Gujarat from July 2009 to March 2010.
Rana H; Parikh P; Shah AN; Gandhi S
J Assoc Physicians India; 2012 Feb; 60():95-7. PubMed ID: 22715554
[TBL] [Abstract][Full Text] [Related]
40. Simplified screening method for detecting oseltamivir resistant pandemic influenza A (H1N1) 2009 virus by a RT-PCR/restriction fragment length polymorphism assay.
Nukiwa N; Suzuki A; Furuse Y; Shimabukuro K; Odagiri T; Khandaker I; Oshitani H
J Virol Methods; 2010 Dec; 170(1-2):165-8. PubMed ID: 20833206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
